We recently demonstrated that antithrombin (AT) reduces ischemia/reperfusion (I/R)-induced liver injury in rats by increasing hepatic tissue levels of calcitonin gene-related peptide (CGRP), a neuropeptide released from the sensory nerve endings. In the present study, we examined the effect of AT on I/R-induced liver injury in wildtype mice (CGRP^+/+^) and congenital α CGRP-deficient mice (CGRP^-/-^). We further investigated whether AT affects CGRP release from dorsal root ganglion neurons (DRG) isolated from CGRP^+/+^. Based on results obtained in the present study, we attempted to determine whether the anti-inflammatory activity of AT *in vivo*is dependent mainly on sensory neuron activation. AT enhanced I/R-induced increases in hepatic tissue levels of CGRP and 6-keto-PGF~1α~a stable metabolite of PGI~2~, in CGRP^+/+^, while it did not enhance these increases in CGRP^-/-^. AT inhibited reperfusion-induced increases in serum alanine aminotransferase levels by increasing hepatic tissue blood flow and by attenuating increases in hepatic levels of tumor necrosis factor and myeloperoxidase in CGRP^+/+^, while it showed neither of these therapeutic effects in CGRP^-/-^. AT increased CGRP release from cultured DRGs only in the presence of anandamide, and the AT-induced increase in CGRP release was not observed in the presence of KT5720, an inhibitor of protein kinase A (PKA). AT markedly increased intracellular levels of cAMP in the presence of anandamide. In conclusion, these results strongly suggest that AT might reduce I/R-induced liver injury by enhancing activation of the sensory neurons through activation of PKA in sensory neurons.
